TYPE 2 DIABETES TREATMENTS SHOULD FOCUS ON WEIGHT LOSS

 

TYPE 2 DIABETES TREATMENTS SHOULD FOCUS ON WEIGHT LOSS






An international panel of experts from four renowned diabetes research centers, including U.T. Southwestern Medical Center, has reviewed current literature and recommends a pivotal change in the treatment of Type 2 diabetes to focus on obesity first and glucose control second.

"It's known that obesity contributes to the progression of diabetes. What's new is that instead of focusing exclusively on lowering blood sugar, we recommend the primary approach to the treatment of Type 2 diabetes be on the treatment of obesity," said first author Ildiko Lingvay, M.D., M.P.H., M.S.C.S.

The researchers state that dropping 15% or more of body weight can have a disease-modifying effect in Type 2 diabetes, an outcome that is unattainable by any other glucose-lowering intervention. The new focus would require updating current treatment guidelines and providing significant provider education, they note. The panel's recommendations are published in The Lancet and were presented at the European Association for the Study of Diabetes conference.

The current approach to diabetes treatment relies on clinical studies from the 1980s, which found that lowering blood sugar results in fewer complications from the disease. These early results supported treating blood glucose as the critical target, said Dr. Lingvay.

"The problem with this approach is that it doesn't address the core problem and does not offer an opportunity to reverse the disease," said Dr. Lingvay, who leads an active clinical research program in the Division of Endocrinology at U.T. Southwestern. "We propose using a proactive approach. Let's address the cause of the disease -- obesity."


According to the American Diabetes Association, Type 2 diabetes is a progressive disease caused by obesity or abnormalities in metabolism. More than 10% of the U.S. population has diabetes, and 1.5 million more are diagnosed each year.

Bariatric surgery can be effective for patients with obesity, but not all patients have access to this option. "It's hard to achieve sustained weight loss. Most lifestyle interventions result in progressive weight loss over six months, followed by a plateau and weight regain over one to three years," added Dr. Lingvay. "New weight loss medications and those in the pipeline will help patients succeed in managing their weight over the long term."

The researchers also stressed the importance of advocating for insurance coverage that supports the treatment of obesity and diabetes and working in public health to increase access to care and reduce disparities.

The authors' disclosures are listed in the manuscript.

Comments

Popular posts from this blog

CRACKING COCONUT OIL'S " HEALTH HALO"

Autophagy:The Body's Anti-aging process

HOW TO LOWER YOUR CHOLESTEROL WITHOUT DRUGS